Immunome grants 86,500 inducement stock options at $27.07 per share

PUBT · 1d ago
Immunome grants 86,500 inducement stock options at $27.07 per share
  • Immunome granted non-statutory stock options for 86,500 shares to four new employees under its 2024 Inducement Plan.
  • Options carry an exercise price of $27.07 per share, set at the Sept. 1, 2026 closing price.
  • Vesting runs four years: 25% after one year, then monthly over the next 36 months, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609081602BIZWIRE_USPR_____20260908_BW670804) on September 08, 2026, and is solely responsible for the information contained therein.